Back to Authors

Unni, K. Krishnan

A5113654214 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 22

Chondroblastoma of the Skull and Facial Bones

American Journal of Clinical Pathology | March 17, 2016 | Volume: 88 | Issue: 1 | Pages: 1-9

10.1093/ajcp/88.1.1 | PMID 3604981

Xanthoma of Bone

American Journal of Clinical Pathology | March 17, 2016 | Volume: 90 | Issue: 4 | Pages: 377-384

10.1093/ajcp/90.4.377 | PMID 3140652

Cartilaginous Tumors of the Larynx: A Series of 33 Patients

Otolaryngology–Head and Neck Surgery | November 25, 2015 | Volume: 90 | Issue: 2 | Pages: 201-207

10.1177/019459988209000212 | PMID 6810266

From 1910 to 1979, 33 patients were seen for treatment of cartilaginous tumors of the larynx. Most of the patients had hoarseness and dyspnea, several had impaired vocal cord mobility, and one third had a lump low in the neck. A diagnosis of grade 1 chondrosarcoma was made in 21 patients, grade 2 chondrosarcoma in 10 patients, and benign chondroma in 2 patients. Most of the tumors were removed by way of laryngofissure (thyrotomy) and some by total laryngectomy. This paper describes the outcome, including retreatment for recurrence.
Advanced giant cell granuloma: A twenty‐year study

Otolaryngology–Head and Neck Surgery | November 25, 2015 | Volume: 110 | Issue: 4 | Pages: 413-418

10.1177/019459989411000411 | PMID 8170686

Giant cell granuloma is a benign lesion that generally involves the mandible and maxilla. It may be locally aggressive and result in extensive tissue destruction in advanced cases. A retrospective analysis of giant cell granuloma during the Interval 1970 to 1990 revealed 18 cases of advanced disease, as defined by bone destruction and a greatest dimension of 2.0 cm or more. Epidemiologic factors, physical findings, Imaging studies, pathologic specimens, treatment modalities, and outcome were reviewed for each case. Eight lesions were treated by local excision and curettage, and 10 were treated by partial mandibulectomy. Five mandibular defects were reconstructed with lilac bone grafts and one with a free flap. Only one patient with maxillary giant cell granuloma who underwent curettage had regrowth of what is suspected to have been residual disease. Individualized treatment, tailoring the extent of resection to the extent of disease, provided excellent results.
Imaging Findings in Desmoplastic Fibroma of Bone: Distinctive T2 Characteristics

American Journal of Roentgenology | February 28, 2013 | Volume: 184 | Issue: 6 | Pages: 1762-1767

10.2214/ajr.184.6.01841762 | PMID 15908527

Solid Variant of Aneurysmal Bone Cysts in Long Tubular Bones: Giant Cell Reparative Granuloma

American Journal of Roentgenology | February 28, 2013 | Volume: 180 | Issue: 6 | Pages: 1681-1687

10.2214/ajr.180.6.1801681 | PMID 12760943

Multicentric Osteosarcoma

American Journal of Clinical Pathology | October 26, 2011 | Volume: 136 | Issue: 5 | Pages: 799-807

10.1309/ajcp0v0oatkcnazp | PMID 22031320

Abstract Multicentric osteosarcoma (M-OGS) is characterized by multicentricity of osseous osteosarcomas, either synchronous or metachronous, without visceral involvement. The study’s purpose was to clinicopathologically and radiographically analyze 56 cases of M-OGS (22 synchronous and 34 metachronous). The distal femur was the most common site. Histologically, all tumors were high grade. Of 22 patients with synchronous M-OGS, 16 had 3 or more simultaneous tumors; the axial skeleton was involved in 14 (64%) of 22 cases. In metachronous M-OGS, the second malignancy occurred after a median of 22 months. Treatment was surgery, chemotherapy, radiotherapy, or a combination of these. Patients with metachronous osteosarcoma had a median survival longer than did patients with synchronous tumors. Overall, 8 long-term survivors were treated by aggressive surgery with wide margins (plus chemotherapy and/or radiotherapy). M-OGS combines multiple skeletal locations of high-grade conventional osteosarcomas and has a poor prognosis. Aggressive surgery may result in improved long-term survival, particularly in patients with metachronous disease.
Intraabdominal Myositis Ossificans: A Report of 9 New Cases

International Journal of Surgical Pathology | June 21, 2007 | Volume: 14 | Issue: 1 | Pages: 37-41

10.1177/106689690601400107 | PMID 16501833

Intraabdominal myositis ossificans (IMO) is a rare benign disorder characterized by reactive bone formation in intraabdominal soft tissue that should be distinguished from a malignant condition. We retrospectively searched our patient records and report 9 new cases of IMO. The lesions occurred in 7 men and 2 women with a mean age of 50 years (range, 24-76 years), 5 of whom had previous abdominal surgery. Histologically, all the cases were similar, consisting of a reactive mesenchymal process in adipose tissue. Mitosis was observed, but with no atypical forms, and the lesions lacked malignant cytologic features. IMO is an uncommon benign lesion that develops relatively rapidly. The pathogenesis is related to intraabdominal surgical procedures, but the exact mechanism remains to be determined.
Malignant giant cell tumor of soft parts. An ultrastructural study of four cases

Cancer | June 30, 2006 | Volume: 40 | Issue: 1 | Pages: 244-253

10.1002/1097-0142(197707)40:1<244::aid-cncr2820400137>3.0.co;2-# | PMID 195704

Sarcomatous Transformation in Cranial Chordoma

Neurosurgery | July 30, 2004 | Volume: 31 | Issue: 1 | Pages: 13-18

10.1097/00006123-199207000-00003